Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Sarcoma & Bone Cancer January 2013 This bulletin covers sarcomas, soft tissue tumours and bone cancers, and should be of interest to multidisciplinary teams working in this area. Sections can include: Combined Modality Therapies Drug Therapy Pathology, Staging, Polymorphisms & Biomarkers Prognosis, Survival & Risk Factors Radiotherapy & Imaging Supportive Care & Symptom Management Surgery Many of the following articles are available online via the NHS Scotland Knowledge Network. Please use the links where provided and your ATHENS password. A complete list of available online journals and registration for ATHENS can be found at www.knowledge.scot.nhs.uk/ If the article you require is not available via the NHS Scotland Knowledge Network and you would like to request a print copy, please submit your request online at www.quest.scot.nhs.uk This bulletin contains a selection of material gathered from a search of the evidence base, and is not intended to be comprehensive. Professional judgment should be exercised when appraising the material. The Library takes no responsibility for the wording, content and accuracy of the information supplied, which has been extracted in good faith from reputable sources. NHSGGC is not responsible for the content of external internet sites. Compiled by: Kirsty Coltart Subject Librarian Beatson West of Scotland Cancer Centre 0141 301 7285, [email protected] 1 Sarcoma & Bone Cancers, January 2013 Kirsty Coltart, Subject Librarian, NHSGGC Library Network General Bell, S.W., Young, P.S. and Mahendra, A. (2012). Primary bone tumours of the talus: the Scottish Bone Tumour Registry experience. Journal of Foot & Ankle Surgery 18,4:277282. Bloch, O. and Parsa, A.T. (2013). Skull base chondrosarcoma: evidence-based treatment paradigms. Neurosurgery clinics of North America 24,1:89-96. Kim, H.J., McLawhorn, A.S., Goldstein, M.J., et al. (2012). Malignant osseous tumors of the pediatric spine. Journal of the American Academy of Orthopaedic Surgeons 20,10:646656. Parida, L., Fernandez-Pineda, I., Uffman, J., et al. (2012). Clinical management of Ewing sarcoma of the bones of the hands and feet: a retrospective single-institution review. Journal of pediatric surgery 47,10:1806-1810. Rakha, E.A., Tan, P.H., Shaaban, A., et al. (2013). Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumours. Breast 22,1:13-18. Stanelle, E.J., Christison-Lagay, E.R., Healey, J.H., et al. (2013). Pediatric and adolescent synovial sarcoma: multivariate analysis of prognostic factors and survival outcomes. Annals of Surgical Oncology 20,1:73-79. Combined Modality Therapies Denbo, J.W., Shannon Orr, W., Wu, Y., et al. (2012). Timing of surgery and the role of adjuvant radiotherapy in ewing sarcoma of the chest wall: a single-institution experience. Annals of Surgical Oncology 19,12:3809-3815. Dharmarajan, K.V., Wexler, L.H. and Wolden, S.L. (2013). Concurrent radiation with irinotecan and carboplatin in intermediate- and high-risk rhabdomyosarcoma: A report on toxicity and efficacy from a prospective pilot phase II study. Pediatric Blood & Cancer 60,2:242-247. Woll, P.J., Reichardt, P., Le Cesne, A., et al. (2012). Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncology 13,10:1045-1054. Drug & Targeted Therapy Bernthal, N.M., Federman, N., Eilber, F.R., et al. (2012). Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma. Cancer 118,23:5888-5893. Indelicato, D.J. and Finkelstein, S.E. (2012). Dendritic cell immunotherapy in soft tissue sarcoma. Immunotherapy 4,10:1023-1029. Le Cesne, A., Cresta, S., Maki, R.G., et al. (2012). A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas. European journal of cancer 48,16:3036-3044. 2 Sarcoma & Bone Cancers, January 2013 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Leahy, M., Garcia Del Muro, X., Reichardt, P., et al. (2012). Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study. Annals of Oncology 23,10:2763-2770. Mulder, R.L., Paulides, M., Langer, T., et al. (2012). Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients. Cochrane Database of Systematic Reviews 12,006300. Womer, R.B., West, D.C., Krailo, M.D., et al. (2012). Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology 30,33:41484154. Pathology, Staging, Polymorphisms & Biomarkers Flores, R.J., Li, Y., Yu, A., et al. (2012). A systems biology approach reveals common metastatic pathways in osteosarcoma. BMC Systems Biology 6,50. Janeway, K.A. and Maki, R.G. (2012). New strategies in sarcoma therapy: linking biology and novel agents. Clinical Cancer Research 18,21:5837-5844. Kamiya, N., Suzuki, H., Endo, T., et al. (2012). Clinical usefulness of bone markers in prostate cancer with bone metastasis. International Journal of Urology 19,11:968-979. Stacchiotti, S., Verderio, P., Messina, A., et al. (2012). Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy. Cancer 118,23:5857-5866. Wright, S., Armeson, K., Hill, E.G., et al. (2012). The role of sentinel lymph node biopsy in select sarcoma patients: a meta-analysis. American Journal of Surgery 204,4:428433. Prognosis, Survival & Risk Factors Chan, J.Y., Wong, S.T., Lau, G.I., et al. (2012). Postradiation sarcoma after radiotherapy for nasopharyngeal carcinoma. Laryngoscope 122,12:2695-2699. Choi, A.H., Barnholtz-Sloan, J.S. and Kim, J.A. (2012). Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis. Annals of Oncology 23,9:2449-2457. Hendifar, A.E., Ahlmann, E., Allison, D.C., et al. (2012). Moving beyond response criteria: new measures of success in the treatment of sarcomas. Current Treatment Options in Oncology 13,3:299-305. Khaliq, W., Meyer, C.F., Uzoaru, I., et al. (2012). Prostate angiosarcoma: is there any association with previous radiation therapy?. BJU international 110,11:E819-25. Morgan, E.A., Kozono, D.E., Wang, Q., et al. (2012). Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Annals of Surgical Oncology 19,12:3801-3808. 3 Sarcoma & Bone Cancers, January 2013 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Radiotherapy & Imaging Garg, A.K., Shiu, A.S., Yang, J., et al. (2012). Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer 118,20:5069-5077. Haas, R.L., Delaney, T.F., O'Sullivan, B., et al. (2012). Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where? International journal of radiation oncology, biology, physics 84,3:572-580. McGee, L., Indelicato, D.J., Dagan, R., et al. (2012). Long-term results following postoperative radiotherapy for soft tissue sarcomas of the extremity. International journal of radiation oncology, biology, physics 84,4:1003-1009. Soldatos, T., Chalian, M., Attar, S., et al. (2013). Imaging differentiation of pathologic fractures caused by primary and secondary bone tumors. European Journal of Radiology 82,1:e36-42. Roeder, F., Schulz-Ertner, D., Nikoghosyan, A.V., et al. (2012). A clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma. BMC Cancer 12,287. Weksberg, D.C., Palmer, M.B., Vu, K.N., et al. (2012). Generalizable class solutions for treatment planning of spinal stereotactic body radiation therapy. International journal of radiation oncology, biology, physics 84,3:847-853. Supportive Care & Symptom Management Brodowicz, T., O'Byrne, K. and Manegold, C. (2012). Bone matters in lung cancer. Annals of Oncology 23,9:2215-2222. Fitzpatrick, D., Grabarz, D., Wang, L., et al. (2012). How effective is a virtual consultation process in facilitating multidisciplinary decision-making for malignant epidural spinal cord compression?. International journal of radiation oncology, biology, physics 84,2:e167-72. Hadji, P., Aapro, M., Costa, L., et al. (2012). Antiresorptive treatment options and bone health in cancer patients-safety profiles and clinical considerations. Cancer treatment reviews 38,6:815-824. Lipton, A., Fizazi, K., Stopeck, A.T., et al. (2012). Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials. European journal of cancer 48,16:3082-3092. Morgans, A.K. and Smith, M.R. (2012). Bone-targeted agents: preventing skeletal complications in prostate cancer. Urologic Clinics of North America 39,4:533-546. Peddi, P., Lopez-Olivo, M.A., Pratt, G.F., et al. (2013). Denosumab in patients with cancer and skeletal metastases: A systematic review and meta-analysis. Cancer treatment reviews 39,1:97-104. So, A., Chin, J., Fleshner, N., et al. (2012). Management of skeletal-related events in patients with advanced prostate cancer and bone metastases: Incorporating new agents into clinical practice. Canadian Urological Association Journal 6,6:465-470. 4 Sarcoma & Bone Cancers, January 2013 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Zeng, L., Chow, E., Bedard, G., et al. (2012). Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22. International journal of radiation oncology, biology, physics 84,3:e337-42. Zeng, L., Chow, E., Zhang, L., et al. (2012). An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases. Supportive Care in Cancer 20,12:3307-3313. Surgery Di Maio, S., Ramanathan, D., Garcia-Lopez, R., et al. (2012). Evolution and future of skull base surgery: the paradigm of skull base meningiomas. World Neurosurgery 78,34:260-275. Eastley, N., Newey, M. and Ashford, R.U. (2012). Skeletal metastases - the role of the orthopaedic and spinal surgeon. Surgical oncology 21,3:216-222. Hasan, K., Racano, A., Deheshi, B., et al. (2012). Prophylactic antibiotic regimens in tumor surgery (PARITY) survey. BMC Musculoskeletal Disorders 13,91. Malviya, A. and Gerrand, C. (2012). Evidence for orthopaedic surgery in the treatment of metastatic bone disease of the extremities: a review article. Palliative medicine 26,6:788-796. Vinals, J.M., Rodrigues, T.A., Sildenikova, D.P., et al. (2012). Indications of microsurgery in soft tissue sarcomas. Journal of reconstructive microsurgery 28,9:619-625. Zhang, T., Li, W., Dai, C., et al. (2013). Evidence-based surgical management of T1 or T2 temporal bone malignancies. Laryngoscope 123,1:244-248. Please note that the journal articles you are accessing are subject to the terms and conditions imposed by the publisher, so there will be a limit on the number of articles an individual may download or print from a single issue of a journal. You can consult your local NHSGGC library with any queries. If you have any questions regarding this or any other library services please contact Library staff – contact details are at the beginning of the bulletin. Sources used for this bulletin: OVID databases 5 Sarcoma & Bone Cancers, January 2013 Kirsty Coltart, Subject Librarian, NHSGGC Library Network